In the tech sector, investors should buy Meta (META) and Oracle (ORCL), Seaport Securities' Ted Weisberg, the firm's founder and president, told Schwab TV today. Meta's valuation is relatively low, "and it's still a big growth stock. At some point, it will be OK, although they don't ring a bell and tell us" when that will be, Weisberg said.

And although tech names in general are currently struggling, "at some point they'll be OK because that is still at the end of the day where the growth is and that's where the earnings are," he said. As a result, he does not recommend that investors sell their tech stocks.

Weisberg Likes Large Pharmaceutical Names

Despite the uncertainty caused by political developments in Washington, a number of sectors are performing well, said Weisberg. Among large pharmaceutical names, which have struggled for the last two years, Bristol Myers (BMY) recently reached new highs, and Pfizer (PFE), which has had its problems for a long time, is beginning to perk up, he reported.

"We own the big pharmaceutical stocks," he said.

Weisberg Recommends Two European Stocks

Among European stocks, Weisberg touted Nestle (NSRGY) and France-based EssilorLuxottica (ESLOY) which develops and markets glasses and lenses. He owns both of those stocks.

While we acknowledge the potential of META, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than META but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.